[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Landspitali University Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":73},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,49],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":30,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":4},"100617128","omega-cold-supplementation-with-free-fatty-acids-for-the-prevention-of-respiratory-infections-in-adults-100617128",false,"NCT07314593","Omega-Cold Supplementation With Free Fatty Acids for the Prevention of Respiratory Infections in Adults.","Effectiveness of Cod-Derived Omega Oil Enriched With Free Fatty Acids Against the Common Cold and Other Respiratory Infections in Healthy Icelandic Adults During the Influenza Season","OmegaCold FFA","Inclusion Criteria: To be in general good health, be between 18 to 80 years of age and be willing and able to take fish oil orally.\n\n\\-\n\nExclusion Criteria: Younger than 18 years and older than 80 years.\n\n\\-",true,"ALL","18 Years","80 Years",{"count":22,"type":23},400,"ESTIMATED","INTERVENTIONAL",[26],"NA","The purpose of this study is to investigate whether fish oil containing free fatty acids affects people's susceptibility to viral infections such as colds, influenza, and COVID-19, as well as the course of these illnesses. Omega Cold is purified fish oil with 2% added free fatty acids, making it similar in that respect to less-purified fish oils. Participants aged 18-80 in generally good health will be recruited through Matís' consumer mailing list and social media advertisements. A total of 400 participants are planned: 100 in the winter of 2025-2026 and 300 in the winter of 2026-2027. Participants will be randomly assigned to two equal groups. One group will take Omega Cold orally twice a day for four months, while the other receives a placebo (vegetable oil) taken in the same way. They will not be asked to change any other habits. All participants will report weekly on their health and any cold or flu symptoms during the time they take the oil, using short questionnaires. The study is scheduled to begin in December 2025, when the oil will be sent to participants.",[29],"Respiratory Infections",[31,32,33,34,35,36],"Free Fatty Acids","Common Cold","respiratory infections","Omega-3","Influenza","COVID-19","NOT_YET_RECRUITING","2025-12-18",{"date":40,"type":41},"2026-01-02","ACTUAL",{"date":43,"type":23},"2025-12-19",{"date":45,"type":23},"2027-08-31",{"name":47,"class":48},"Landspitali University Hospital","OTHER",{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":59,"phases":4,"briefSummary":60,"conditions":61,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},"100258789","treatment-as-prevention-for-hepatitis-c-in-iceland-100258789","NCT02647879","Treatment as Prevention for Hepatitis C in Iceland","Treatment as Prevention for Hepatitis C in Iceland. A Nationwide Campaign for Reducing Disease Burden Using Combination Antiviral Treatment","TraPHepC","Inclusion Criteria:\n\n* HCV positive subjects 18 years and older, living in Iceland and covered by the Icelandic Health Insurance.\n\nExclusion Criteria:\n\n* Age under 18 years\n* Inability to sign informed consent.",{"count":58,"type":23},1000,"OBSERVATIONAL","The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.",[62],"Hepatitis C","RECRUITING","2020-09-24",{"date":66,"type":41},"2020-09-25",{"date":68,"type":4},"2016-01",{"date":70,"type":23},"2031-05",{"name":47,"class":48},1,""]